You are here

Merck weighing acquisition of Cubist for more than US$7b: sources

Deal, if announced, would be another multibillion-dollar health care transaction in a banner year for M&A
Monday, December 8, 2014 - 05:50

New York

DRUGMAKER Merck & Co is in talks to acquire the biopharmaceuticals company Cubist for more than US$7 billion, according to people briefed on the matter.

The deal, if announced, would represent another multibillion-dollar health care transaction in a banner year for

sentifi.com

Market voices on:

Powered by GET.comGetCom